Ivan Gardini

401 total citations
16 papers, 253 citations indexed

About

Ivan Gardini is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Ivan Gardini has authored 16 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 9 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in Ivan Gardini's work include Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (6 papers) and Hepatitis B Virus Studies (4 papers). Ivan Gardini is often cited by papers focused on Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (6 papers) and Hepatitis B Virus Studies (4 papers). Ivan Gardini collaborates with scholars based in Italy, United Kingdom and Germany. Ivan Gardini's co-authors include S. Fagiuoli, Roberta Ciampichini, Laura Gaeta, L Scalone, A. Del Prete, LG Mantovani, Francesco Fusco, Giancarlo Cesana, Francesco Saverio Mennini and Marco Bartoli and has published in prestigious journals such as PLoS ONE, Journal of Hepatology and Quality of Life Research.

In The Last Decade

Ivan Gardini

15 papers receiving 249 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ivan Gardini 115 97 88 32 25 16 253
Daniel Newman 124 1.1× 220 2.3× 18 0.2× 50 1.6× 77 3.1× 12 377
Ivy Tonnu-Mihara 142 1.2× 134 1.4× 32 0.4× 25 0.8× 5 0.2× 19 227
Mina Kabiri 237 2.1× 239 2.5× 14 0.2× 17 0.5× 35 1.4× 19 356
Devika Kapuria 146 1.3× 174 1.8× 27 0.3× 15 0.5× 38 1.5× 28 404
Qi Cao 11 0.1× 94 1.0× 96 1.1× 31 1.0× 12 0.5× 26 345
Daniel K. Onion 33 0.3× 65 0.7× 21 0.2× 99 3.1× 24 1.0× 8 302
Cathy Matheï 83 0.7× 123 1.3× 9 0.1× 35 1.1× 18 0.7× 21 304
Lawrence Shaw 29 0.3× 38 0.4× 53 0.6× 54 1.7× 50 2.0× 18 362
Franco Wing Tak Cheng 34 0.3× 54 0.6× 34 0.4× 19 0.6× 28 1.1× 36 324
Kim Gilchrist 76 0.7× 67 0.7× 36 0.4× 15 0.5× 108 4.3× 18 344

Countries citing papers authored by Ivan Gardini

Since Specialization
Citations

This map shows the geographic impact of Ivan Gardini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Gardini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Gardini more than expected).

Fields of papers citing papers by Ivan Gardini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Gardini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Gardini. The network helps show where Ivan Gardini may publish in the future.

Co-authorship network of co-authors of Ivan Gardini

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Gardini. A scholar is included among the top collaborators of Ivan Gardini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Gardini. Ivan Gardini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Pugliese, Nicola, Davide Polverini, Rosa Lombardi, et al.. (2024). Evaluation of ChatGPT as a Counselling Tool for Italian-Speaking MASLD Patients: Assessment of Accuracy, Completeness and Comprehensibility. Journal of Personalized Medicine. 14(6). 568–568. 6 indexed citations
2.
Andreoni, Massimo, Nicola Coppola, Antonio Craxı̀, et al.. (2022). Meet–Test–Treat for HCV management: patients’ and clinicians’ preferences in hospital and drug addiction services in Italy. BMC Infectious Diseases. 22(1). 3–3. 4 indexed citations
3.
Kondili, Loreta A., Alessio Aghemo, Massimo Andreoni, et al.. (2021). Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation. Digestive and Liver Disease. 54(2). 237–242. 19 indexed citations
4.
Masarone, Mario, Marco Bartoli, Maria Letizia Conforti, et al.. (2021). Associated screening for HCV and SARS-Cov2 infection in an urban area of Southern Italy: the “Casola di Napoli” cohort study. Digestive and Liver Disease. 53. S2–S3.
5.
Coppola, Carmine, Mario Masarone, Marco Bartoli, et al.. (2021). Associated screening for HCV and SARS‐Cov2 infection in an urban area of Southern Italy: A cohort study. Journal of Viral Hepatitis. 29(2). 171–173. 4 indexed citations
6.
Gardini, Ivan, et al.. (2019). Estimation of the number of HCV-positive patients in Italy. PLoS ONE. 14(10). e0223668–e0223668. 10 indexed citations
7.
Tecco, Simona, Giorgio Gastaldi, Elisabetta Polizzi, et al.. (2019). Point-of-care testing for hepatitis C virus infection at an Italian dental clinic: portrait of the pilot study population.. PubMed. 42(3). 133–138. 13 indexed citations
8.
Tecco, Simona, Giorgio Gastaldi, Elisabetta Polizzi, et al.. (2017). Point-of-care testing for hepatitis C virus infection at alternative and high-risk sites: an Italian pilot study in a dental clinic.. PubMed. 40(4). 242–245. 12 indexed citations
9.
Invernizzi, Pietro, Annarosa Floreani, Marco Carbone, et al.. (2017). Primary Biliary Cholangitis: advances in management and treatment of the disease. Digestive and Liver Disease. 49(8). 841–846. 21 indexed citations
10.
Gardini, Ivan, et al.. (2016). HCV: Estimation of the Number of Diagnosed Patients Eligible to New Anti-HCV Therapies in Italy. Value in Health. 19(7). A510–A510. 8 indexed citations
11.
Scalone, L, S. Fagiuoli, Roberta Ciampichini, et al.. (2015). The societal burden of chronic liver diseases: results from the COME study. BMJ Open Gastroenterology. 2(1). e000025–e000025. 37 indexed citations
12.
Ciampichini, Roberta, L Scalone, S. Fagiuoli, et al.. (2012). PGI18 Societal Burden in Hepatits C Patients: The Come Study Results. Value in Health. 15(4). A138–A138. 3 indexed citations
13.
Fusco, Francesco, L Scalone, S. Fagiuoli, et al.. (2012). PGI17 Societal Burden in Patients with Liver Transplantation: The Come Study Results. Value in Health. 15(4). A138–A138. 1 indexed citations
14.
Gardini, Ivan, et al.. (2012). PGI32 New Antiviral Drugs for Hepatitis C in Italy: Will it be a Treasure Hunt?. Value in Health. 15(7). A331–A332. 1 indexed citations
15.
Scalone, L, Roberta Ciampichini, S. Fagiuoli, et al.. (2012). Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases. Quality of Life Research. 22(7). 1707–1716. 109 indexed citations
16.
Fagiuoli, S., L Scalone, Roberta Ciampichini, et al.. (2012). 25 SOCIETAL BURDEN IN PATIENTS WITH CHRONIC HEPATIC DISEASES: THE COME STUDY RESULTS. Journal of Hepatology. 56. S11–S12. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026